10x Genomics, Inc..
TXG.US | Research and experimental development on natural sciences and engineering
10x Genomics, Inc. is a biotechnology company that develops and sells instruments, consumables, and software for analyzing biological systems. Their products are used by researchers in a variety of fields, including genomics, immunology, and cancer biology, to study the molecular biology of cells an...Show More
Better Health for All
0
10x Genomics' principal goods and services, including instruments, consumables, and software for analyzing biological systems, are entirely dedicated to enabling research that advances human health. These technologies are used in fields such as oncology, immunology, neuroscience, drug discovery, personalized medicine, and women's health, accelerating the discovery of new therapies and diagnostics.
1
Over 8,200 publications have utilized their products.
2
There is no evidence that any of the company's products or activities have negative health outcomes or direct safety implications for physical or mental health.
3
Fair Money & Economic Opportunity
0
10x Genomics, Inc. is a biotechnology company that develops and sells instruments, consumables, and software for analyzing biological systems. The company's core business does not involve lending, insuring, moving, or storing money, nor does it offer consumer financial products or services.
1
The provided articles discuss product pricing for scientific tools,
2
internal diversity initiatives,
3
and financial performance,
4
but none of this information is relevant to the specific KPIs for 'Fair Money & Economic Opportunity', which are designed for financial institutions or companies with financial service offerings. Therefore, all KPIs are omitted due to a lack of applicable data.
Fair Pay & Worker Respect
10
The company's CEO to median employee pay ratio was 39:1 for the 2024 fiscal year.
1
In 2023, the company set corporate goals to achieve an overall employee engagement score of 80%+, an inclusion and diversity score of 75%+, and an employee well-being score of 75%+.
2
The voluntary employee turnover rate in 2023 was 10.5%, which is below U.S. and global industry averages.
3
The company had a corporate goal in 2023 to maintain an ethical and compliant culture with no adverse regulatory actions.
4
None of the company's U.S. employees are represented by a labor union or covered under a collective bargaining agreement, and the same applies to international employees apart from standard industry-wide or compulsory agreements.
5
The company offers a competitive and comprehensive health benefits package, with executive officers eligible to participate in all employee benefit plans on the same basis as other employees.
6
The company conducted a reduction in force in August 2022 and committed to a restructuring plan in December 2023 related to the closure of a research and development facility, which impacted 8% of its workforce (100 jobs) in Q2 2025.
7
Fair Trade & Ethical Sourcing
0
No evidence available to assess 10x Genomics, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No evidence available to assess 10x Genomics, Inc. on Honest & Fair Business.
Kind to Animals
-40
10x Genomics conducts animal testing for medical analysis and clinical research.
1
However, the company also develops and uses alternative testing methods such as artificial skin, silicon microphysiometers, and cultured organ systems.
2
Its policy expects suppliers to adopt humane approaches and consider ways to reduce and replace animal usage.
3
Historically, the development of monoclonal antibodies, which replaced a method requiring one rabbit per pregnancy, led to a reduction in animal sacrifice.
4
Over 5,000 mice are used annually in lung fibrosis research, a field where 10x Genomics' technology is used in human models by collaborators.
5
In 2017, 10x Genomics' Supernova Assembler was used to assemble the genome of the endangered African wild dog, a species with less than 7,000 remaining in the wild, in collaboration with several conservation and research organizations.
6
The company is listed on crueltyfreeinvesting.org for exploiting animals due to its animal testing practices.
7
No War, No Weapons
0
No evidence available to assess 10x Genomics, Inc. on No War, No Weapons.
Planet-Friendly Business
0
No specific, quantitative data points were found across the provided articles for any of the Planet-Friendly Business KPIs. The articles explicitly state a lack of publicly available data for all relevant environmental metrics, including Scope 1, 2, and 3 emissions, renewable energy usage, water consumption, waste diversion, and the existence of science-based targets or environmental certifications.
1
While one article mentions 'GHG Emissions' and 'Waste' as negative impact categories in a broader net impact assessment, it does not provide the specific quantitative data required by the rubric's KPIs (e.g., tCO₂e for GHG emissions or percentage diversion for waste).
2
Respect for Cultures & Communities
0
No evidence available to assess 10x Genomics, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No evidence available to assess 10x Genomics, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No specific, quantitative data related to waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability scores, waste audit frequency, zero-waste certifications, waste disposal violations, material efficiency, packaging to product ratio, waste reduction targets, supplier waste requirements, or customer waste education was found in the provided articles.
1
The company's Form 10-K explicitly states significant data gaps exist regarding its sustainability practices.
2